EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
March 31, 2026 2.328
December 31, 2025 2.256
September 30, 2025 1.663
June 30, 2025 1.186
March 31, 2025 0.7815
December 31, 2024 0.476
September 30, 2024 0.4292
June 30, 2024 0.0594
March 31, 2024 0.3248
December 31, 2023 0.3653
September 30, 2023 0.5119
June 30, 2023 0.805
March 31, 2023 0.706
December 31, 2022 0.8948
September 30, 2022 1.148
June 30, 2022 1.214
March 31, 2022 1.451
December 31, 2021 1.315
September 30, 2021 1.200
June 30, 2021 1.342
March 31, 2021 1.058
December 31, 2020 1.091
September 30, 2020 1.069
June 30, 2020 0.8273
March 31, 2020 0.9063
Date Value
December 31, 2019 0.9394
September 30, 2019 1.010
June 30, 2019 1.350
March 31, 2019 1.678
December 31, 2018 1.802
September 30, 2018 1.608
June 30, 2018 1.596
March 31, 2018 1.43
December 31, 2017 1.53
September 30, 2017 1.70
June 30, 2017 1.62
March 31, 2017 1.62
December 31, 2016 1.49
September 30, 2016 1.90
June 30, 2016 2.06
March 31, 2016 1.94
December 31, 2015 1.90
September 30, 2015 1.54
June 30, 2015 1.59
March 31, 2015 0.86
December 31, 2014 0.5324
September 30, 2014 0.1758
June 30, 2014 -0.2642
March 31, 2014 0.2926
December 31, 2013 0.2609

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Zoetis, Inc. 6.036
Omeros Corp. 0.856
Corcept Therapeutics, Inc. 0.35
Merck & Co., Inc. 3.553
Nektar Therapeutics -8.420